Skip to main content
SpringerLink
Log in

Mammakarzinom in Schwangerschaft und Stillzeit

  • Chapter
Management des MAMMAKARZINOMS

Part of the book series: Onkologie ((ONKAKTUELL))

Zusammenfassung

Zwar sind maligne Erkrankungen die Haupttodesursache bei Frauen im gebärfähigen Alter (Silverberg u. Lubera 1986), das Auftreten in der Schwangerschaft ist jedoch relativ selten. Schätzungsweise tritt etwa eine Tumorerkrankung auf 1000 Schwangerschaften auf. Die häufigsten malignen Erkrankungen während der Schwangerschaft sind Tumore aus dem gynäkologischen Bereich. In der Inzidenz führend sind das Zervix- und das Mammakarzinom (Haas 1984; Winkelmann u. Schneider 1991) (Tabelle 20.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ataya K, Moghissi K (1989) Chemotherapy-induced premature ovarian failure: mechanism and prevention. Steroids 54: 607–626

    Article  PubMed  CAS  Google Scholar 

  • Ataya K, Ramahi-Ataya A (1993) Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist. Reprod Toxicol 7: 229–235

    Article  PubMed  CAS  Google Scholar 

  • Aviles A, Diaz Maqueo JC, Talavera A, Guzman R, Garcia EL (1992) Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 36: 243–248

    Article  Google Scholar 

  • Awidi AS, Tarawneh MS, Shubair KS, Issa AA, Dajani YF (1983) Acute leukemia in pregnancy. Report of five cases treated with a combination which included a low dose of adriamycin. Europ J Cancer Clin Oncol 19: 881

    Article  PubMed  CAS  Google Scholar 

  • Baltzer, Konecny, Untch (1996) Mammakarzinom und Schwangerschaft. Mammakarzinom-Manual, Tumorzentrum München, S 103–106

    Google Scholar 

  • Barnavon Y, Wallack MK (1990) Management of the pregnant patient with carcinoma of the breast. Surgery, Gynecol Obstetr 171:347–351

    CAS  Google Scholar 

  • Barker GH (1983) Cytotoxic drugs in pregnancy. In: Lewis P, Wright PSG (eds) Clinical pharmacology in obstetrics. Bristol, pp 144–155

    Google Scholar 

  • Barnicle MM (1992) Chemotherapy and pregnancy. Sem Oncol Nurs 8/2:124–132

    Article  Google Scholar 

  • Blatt J et al. (1980) Pregnancy outcome following cancer chemotherapy. Am J Med 69: 828–832

    Article  PubMed  CAS  Google Scholar 

  • Berkowitz RL, Coustan DR, Mochizuki TK (1986) Handbook for prescibing medications during pregnancy, 2nd edn. Little, Brown, Boston

    Google Scholar 

  • Brincker H et al. (1989) Castration induced by cytotoxic chemotherapy. Letter. J Clin Oncol 7:679–680

    CAS  Google Scholar 

  • Buscema ZA, Stern JL, Johnson TRB (1988) Antineoplastic drugs and pregnancy. In: Niebly JR (ed) Drug use in pregnancy, 2nd edn. Niebly, Lea &; Febiger, pp 89–108

    Google Scholar 

  • Chang YT, Loong CC, Wang HC, Jwo SC, Lui WY (1994) Breast cancer and pregnancy. Chin Med J 54: 223–229

    CAS  Google Scholar 

  • Chaube S, Murphy ML (1965) Teratogenic effects of cytosine arabinoside (CA) in the rat fetus. Proc Am Assoc Cancer Res 6:11

    Google Scholar 

  • Chaube S et al. (1967) Teratogenic effects of cyclophosphamide in the rat. Cancer Chemother Rep 51:363–376

    Google Scholar 

  • Chaube S, Murphy ML (1968) The teratogenic effects of the recent drugs active in cancer chemotherapy. In: Woollam DHM (ed) Advances in teratology, vol 3. Academic Press, New York, pp 204–205

    Google Scholar 

  • Coates A (1970) Cyclophosphamide in pregnancy. Aust NZ J Obstet Gynecol 10:33–34

    Article  CAS  Google Scholar 

  • Committee on Drugs, American Academy of Pediatrics (1989) The transfer of drugs and other chemicals into human breast milk. Pediatrics 84: 924–936

    Google Scholar 

  • Dagg CP (1960) Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil. Am J Anat 106:89–96

    Article  PubMed  CAS  Google Scholar 

  • Dara P et al. (1981) Successful pregnancy during therapy for acute leukemia. Cancer 47: 845–846

    Article  PubMed  CAS  Google Scholar 

  • Darab DJ, Minkoff R, Sciote J et al. (1987) Pathogenesis of median facial clefts in mice treated with methotrexate. Teratology 36: 77–88

    Article  PubMed  CAS  Google Scholar 

  • Diniz EMA, Corradini HB, Ramos JL et al. (1978) The effects of methotrexat on the developing fetus. Rev Hosp Clin Fac Med, Univ Sao Paulo 33: 286–290

    CAS  Google Scholar 

  • Doll DC, Ringenberg QS, Yarbro JW (1988) Management of cancer during pregnancy. Arch Intern Med 148: 2058–2074

    Article  PubMed  CAS  Google Scholar 

  • Doll DC, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16:337–346

    PubMed  CAS  Google Scholar 

  • Durodola JI (1979) Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc 71:165

    PubMed  CAS  Google Scholar 

  • Egan PC, Costanza ME, Dodion P, Egorion MJ, Bachur NR (1985) Doxorubicin and cisplatin excretion into human milk. Cancer Treat Rep 69:1387–1389

    PubMed  CAS  Google Scholar 

  • Elledge RM, Ciocca DR, Langone G, McGuire WL (1992) Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71: 2499–2509

    Article  Google Scholar 

  • Fantel AG et al. (1985) The embryotoxicity of adramycin in rat embryos in vitro. Toxicol Appl Pharmacol 80:155–165

    Article  PubMed  CAS  Google Scholar 

  • Fritz H, Hess R (1971) Effects of cyclophosphamide on embryonic development in the rabbit. Agents Actions 2: 83–86

    Article  PubMed  CAS  Google Scholar 

  • Gallenberg MM, Loprinzi CL (1989) Breast cancer and pregnancy. Semin Oncol 16:369–373

    PubMed  CAS  Google Scholar 

  • Garcia V, San Miguel J, Borrasca AL (1981) Doxorubicin in the first trimester of pregnancy. Ann Intern Med 94:547

    Article  PubMed  CAS  Google Scholar 

  • Gerlinger P, Clavert J (1965) Ano alies observees chez des lapins issus de meres traitees au cyclophosphamide. C R Soc Biol 159:1462–1466

    CAS  Google Scholar 

  • Gililland J, Weinstein L (1983) The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38: 6–13

    PubMed  CAS  Google Scholar 

  • Gleicher N, Scigel I (1981) Common denominators of pregnancy and malignancy. Prog Clin Biol Res 70:339–341

    PubMed  CAS  Google Scholar 

  • Haas JF (1984) Pregnancy in association with a newly diagnosed cancer. A population-based epidemiologic assessment. Int J Cancer 34: 229

    Article  PubMed  CAS  Google Scholar 

  • Hackenberger I, Kreybig T (1965) Vergleichende teratologische Untersuchungen bei der Maus und der Ratte. Arzneim Forsch 15:1456–1460

    CAS  Google Scholar 

  • Hansmann I (1974) Chromosome aberrations in metaphase II-oocytes stage sensitivity in the mouse oogenesis to amethopterin and cyclophosphamide. Mutat Res 22:175–191

    Article  PubMed  CAS  Google Scholar 

  • Hasan C, Fleischhack G, Bode U (1995) Fetale Risiken bei zytotoxischer Malignombehandlung in der Schwangerschaft. Deutscher Krebskongress 20.10.01, Abstractband 22, S184

    Google Scholar 

  • Hassenstein E, Riedel H (1978) Zur Teratogenität von Adriamycin ein Fallbericht. Geburtshilfe Frauenheilkde 38:131–133

    CAS  Google Scholar 

  • Hendrickx AG, Peterson PE, Rowland JR, Tarantal AF (1991) Early embryonic sensitivity to cyclophosphamid in long-tailed monkeys (Macaca fascicularis). Teratology 43:445

    Google Scholar 

  • Hoeffken W, Lanyi M (1977) Mammography. Saunders, Philadelphia

    Google Scholar 

  • Isaacs JH (1995) Cancer of the breast in pregnancy. Surg Clin North America 75: 47–55

    CAS  Google Scholar 

  • Ishida T, Yokoe T, Kasumi F et al. (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn — J — Cancer — Res 83(11): 1143–1149

    Article  PubMed  CAS  Google Scholar 

  • Jensen MK, Nyfors A (1979) Cytogenetic effect of methotrexate on human cells in vivo. Comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by micronucleus test. Mutat Res 64:339–343

    Article  PubMed  CAS  Google Scholar 

  • Johns DG, Rutherford LD, Leighton PC, Vagel CI (1972) Secretion of methotrexate into human milk. Am J Obstet Gynecol 112:978–980

    PubMed  CAS  Google Scholar 

  • Jordan RL, Wilson JG, Schumacher HJ (1977) Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 15:73–80

    Article  PubMed  CAS  Google Scholar 

  • Karp GI, von Oyen P, Valone F et al. (1983) Doxorubicin in pregnancy: possible transplacental passage. Cancer Treatm Rep 67:773–777

    CAS  Google Scholar 

  • Kirshon B et al. (1988) Teratogenic effects of first trimester cyclophosphamide therapy. Obstet Gynecol 72:462

    PubMed  CAS  Google Scholar 

  • Khera KS (1976) Teratogenicity studies with methotrexate, aminopterin, and acetylsalicyclic acid in domestic cats. Teratology 14:21–28

    Article  PubMed  CAS  Google Scholar 

  • Kopelman JN, Miyazawa K (1990) Inadvertent 5-fluorouracil treatment in early pregnancy: a report of three cases. Reprod Toxicol 4:233–235

    Article  PubMed  CAS  Google Scholar 

  • Knörr K, Rauskolb R (1992) Pharmakogene Fruchtschäden. Geburtshilfe, Bd I, Sonderdruck. Thieme, Stuttgart, S 89–96

    Google Scholar 

  • Kreuser ED, Klingmüller D, Thiel E (1992) Diagnostik und Prognose gonadaler Toxizität nach Chemotherapie und Bestrahlung. Dtsch Med Wochenschr 117:1810–1817

    Article  PubMed  CAS  Google Scholar 

  • Khurshid M, Saleem M (1978) Acute leukemia in pregnancy. Lancet II: 534–535

    Article  Google Scholar 

  • Leinmüller R (1996) Fertilität nach Chemotherapie. Schädigung der Ovarien kann minimiert werden. Deutsches Ärzteblatt 93/40: B-1989

    Google Scholar 

  • Lochry E, Kai S, Kohmura H, Kadota T, Takahashi N (1995) Reproductive safety evaluation of paclitaxel in rats. Toxicologist 15: in press

    Google Scholar 

  • Lowenthal RM et al. (1982) Normal infant after combination chemotherapy including teniposide for Burkitts’ lymphoma in pregnancy. Med Pediatr Oncol 10:165–169

    Article  PubMed  CAS  Google Scholar 

  • Maher JF, Schreiner GE (1970) Treatment of lupus nephritis with azathioprine. Arch Intern Med 125:293–298

    Article  PubMed  CAS  Google Scholar 

  • Marazzini F, Macchi L (1966) Two normal pregnancies in patients receiving Cytoxan for Hodgkin’s disease. Ann Obstet Gynecol 88: 825–834

    CAS  Google Scholar 

  • Marchant DJ (1994) Breast cancer in pregnancy. Clin Obst Gyn 37:993–997

    Article  CAS  Google Scholar 

  • Max MH, Klamer TW (1983a) Pregnancy and breast cancer. So Med J 25:241–242

    Google Scholar 

  • Max MH, Klamer TW (1983b) Pregnancy and breast cancer. So Med J 76: 1008–1090

    Article  Google Scholar 

  • Menutti MT, Shepard TH, Mellman WJ (1975) Fetal renal malformation following continuous treatment with adriamycin, bleomycin, vinblastine and imidazole carboxa-mide (ABVD) after failure of MOPP therapy. Cancer 41: 2107–2111

    Google Scholar 

  • Milunsky A, Graef JW, Gaynor MF (1968) Methotrexat-induced congenital malformations. J Pediatr 72:790–795

    Article  PubMed  CAS  Google Scholar 

  • Mondello C, Giorgi R, Nuzzo F (1984) Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat Res 139:67–70

    Article  PubMed  CAS  Google Scholar 

  • Mulvihill JJ, McKeen EA, Rosner F et al. (1987a) Pregnancy outcome in cancer patients. Cancer 60:1143–1150

    Article  PubMed  CAS  Google Scholar 

  • Murray CL, Reichert JA, Anderson J et al. (1984) Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 252: 2607–2608

    Article  PubMed  CAS  Google Scholar 

  • Mutchinick O, Aizpuru E, Grether P (1992) The human teratogenic effect of cyclophosphamide. Teratology 45:329

    Google Scholar 

  • Newcomb M, Balducci L, Thigpen JT, Morrison FS (1978) Acute leukemia in pregnancy: sucessful delivery after cytarabine and doxorubicin. JAMA 239: 2691–2692

    Article  PubMed  CAS  Google Scholar 

  • Nicholson HO (1968) Cytotoxic drugs in pregnancy. J Obstet Gynecol 75:307–312

    CAS  Google Scholar 

  • Odom LD, Plouffe JR, Butler WJ (1990) 5-fluoruracil exposure during the period of conception: A report on two cases. Am J Obstet Gynecol 163:76–77

    PubMed  CAS  Google Scholar 

  • Oguro T et al. (1973) Toxicological studies on adriamycin-HCL. 4. Teratology study. Yakubutsu Ryoho 6:1152–1164

    Google Scholar 

  • Ono C, Iwama A, Fujiwara Y, Kitsuya A, Nakamura T (1992) Teratology study of idarubicin hydrochloride in rats in intravenous injection. Shinyaku to Rinsho 41: 2958–2987

    Google Scholar 

  • Petrek JA, Dukoff R, Rogatko A (1991) Prognosis of pregnancyassociated breast cancer. Cancer 67: 869–872

    Article  PubMed  CAS  Google Scholar 

  • Petrek JA (1991) Pregnancy-associated breast cancer. Sem Surg Oncol 7:306–310

    Article  CAS  Google Scholar 

  • Pizzuto et al. (1980) Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 64: 679–683

    PubMed  CAS  Google Scholar 

  • Powell HR, Ekert H (1971) Methotrexat-induced malformations. Med J Aust 2:1076–1077

    PubMed  CAS  Google Scholar 

  • Reynoso EE, Shepard FA, Messner HA et al. (1987) Acute leukemia during pregnancy: The Toronto Leukemia Studie group experience with long-term follow-up of children exposed in utero to chemotherapeutic agent. J Clin Oncol 5:1098–1106

    PubMed  CAS  Google Scholar 

  • Rister M, Müller AM, Gladtke E (1983) Kinder ehemaliger krebskranker Patienten. Dtsch Med Wochenschr 108: 1137–1140

    Article  PubMed  CAS  Google Scholar 

  • Roboz J, Gleicher N, Wu K et al. (1979) Does doxorubicin cross the placenta? Lancet II, Dec 22/29:1382–1383

    Google Scholar 

  • Rosenshein NB et al. (1979) Pregnancy following chemotherapy for an ovarian immature embryonal teratoma. Gynecol Oncol 24:268–270

    Google Scholar 

  • Rustin GJS, Booth M, Dent J et al. (1984) Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumors. Br Med J 288:103–106

    Article  CAS  Google Scholar 

  • Sanders JE, Bruckner CD et al. (1983) Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36: 252

    Article  PubMed  CAS  Google Scholar 

  • Sanders JE, Bruckner CD, Amos D et al. (1988) Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 6: 813

    PubMed  CAS  Google Scholar 

  • Schoultz E, Johannson H, Wilking N, Rutqvist LE (1995) Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13: 430–434

    Google Scholar 

  • Scialli AR, DeSesso JM, Rahman A, Husain SR, Goeringer GC (1995) Dose-response comparison of free and liposome-encapsulated taxol. Teratology 51:169

    Google Scholar 

  • Scialli AR, Waterhouse TB, DeSesso JM, Rahman A, Goeringer GC (1997) Protective effect of Liposome encapsulation on paclitaxel developmental toxicity in the rat. Teratology 56:305–310

    Article  PubMed  CAS  Google Scholar 

  • Scialli AR, DeSesso JM, Goeringer GC (1994) Taxol toxicity in the developing chick. Teratology 45: 478

    Google Scholar 

  • Scialli AR, DeSesso JM, Goeringer GC (1992) Taxol and embryonic development in the chick. Teratogen Carcinog Mutagen 14: 23–30

    Article  Google Scholar 

  • Silverberg E, Lubera J (1986) Cancer statistics. CA 36:9

    PubMed  CAS  Google Scholar 

  • Sinkovics JG, Shullenberger CC (1969) Pregnancy and systemic malignant disease. Cancer Chemother Rep 53:94

    Google Scholar 

  • Skalko RG, Gold MP (1974) Teratogenicity of methotrexate in mice. Teratology 9:159–164

    Article  PubMed  CAS  Google Scholar 

  • Sosa Munoz JL, Perez Santana MT, Sosa Sanchez R et al. (1983) Acute leukemia and pregnancy. Rev Invest Clin (Mex) 35:55–58

    CAS  Google Scholar 

  • Stadler HE, Knowles J (1971) Fuoruracil in pregnancy: effect on the neonate. JAMA 217: 214–215

    Article  PubMed  CAS  Google Scholar 

  • Stephens JD, Golbus MS, Miller TR, Wilber RR et al. (1980) Multiple congenital anomalies in a fetus exposed to 5-fluoruracil during the first trimester. Am J Obstet Gynecol 137:747–749

    PubMed  CAS  Google Scholar 

  • Sweet DL, Kinzie J (1976) Consequences of radiotherapy and antineoplastic therapy to the fetus. J Reprod Med 17:241–246

    PubMed  Google Scholar 

  • Symington GR et al. (1977) Cancer and teratogenesis. Infrequent occurrence after medical use of immuno-suppressive drugs. Aust N Z J Med 7: 376–378

    Google Scholar 

  • Thomas PR, Biochem D, Peckham MJ (1976) The investigation and management of Hodgkin’s disease in the pregnant patient. Cancer 38:1443–1451

    Article  PubMed  CAS  Google Scholar 

  • Thompson DJ (1974) Reproduction and teratology studies with oncolytic agents in the rat and the rabbit. I. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Toxicol Appl Pharmacol 30: 422–439

    Article  PubMed  CAS  Google Scholar 

  • Tobias JS, Bloom HJG (1980) Doxorubicin in pregnancy. Lancet, Apr 5: 776

    Article  Google Scholar 

  • Toledo TM et al. (1971) Fetal effects during cyclophosphamide and irridiation therapy. Am Intern Med 74: 87–91

    Article  CAS  Google Scholar 

  • Turchi JJ, Villasis C (1988) Anthracyclines in the treatment of malignancy in pregnancy. Cancer 61: 435–440

    Article  PubMed  CAS  Google Scholar 

  • van Thiel DH, Ross GT, Lipsett MB (1970) Pregnancies after chemotherapy of throphoblastic neoplasma. Science 169: 1326–1327

    Article  PubMed  Google Scholar 

  • Voorhees JJ, Janzen MK, Harrell ER, Chakrabarti SG (1969) Cytogenetic evaluation of methotrexate-treated psoriatic patients. Arch Derm 100:269–274

    Article  PubMed  CAS  Google Scholar 

  • Wallack MK, Wolf JA, Bedwenek J et al. (1983) Gestational carcinoma of the female breast. Curr Probl Cancer 7:1–58

    Article  PubMed  CAS  Google Scholar 

  • Warkany J (1978) Aminopterin und Methotrexat: folic acid deficiency. Teratology 17:353–358

    Article  PubMed  CAS  Google Scholar 

  • Wiernick PH, Duncan JH (1971) Cyclophosphamide in human milk. Lancet 1:912

    Article  Google Scholar 

  • Wilk AL et al. (1978) Induction of malformations in the rhesus monkey with cyclophosphamide. Teratology 17: 24a

    Google Scholar 

  • Wilson JG, Scott WJ, Ritter EJ, Fradkin R (1979) Comparative distribution and embryotoxicity of methotrexate in pregnant rats and rhesus monkeys. Teratology 19:71–80

    Article  PubMed  Google Scholar 

  • Wilson JG (1971a) Use of rhesus monkeys in teratological studies. Fed Proc 30:104–109

    PubMed  CAS  Google Scholar 

  • Winkelmann M, Schneider W (1991) Tumortherapie in der Schwangerschaft. Dtsch Med Wochenschr 116:670–673

    PubMed  CAS  Google Scholar 

  • Yamashita H, Tateda C, Yamamae H, Kuzuoka K, Ishitobi H, Nakamura T (1992) Fertility study of idarubicin hydrochloride in rats by intavenous injection. Shinyaku to Rinsho 41: 2948–2957

    Google Scholar 

  • Zemlickis D, Lishner M, Ehrlich R, Koren G (1992) Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratogen Carcinog Mutagen 13:139–143

    Article  Google Scholar 

  • Zirvi KA et al. (1985) Embryotoxic effects of doxorubucin and N-trifluroacetyladriamycin-14-valerate (AD-32). Teratology 31: 247–252

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Adler-Ganal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsfrauenklinik, Universität Ulm, Prittwitzstraße 43, D-89075, Ulm, Deutschland

    Rolf Kreienberg  & Tanja Volm  & 

  2. Städt. Kliniken Frankfurt-Höchst Akademisches Lehrkrankenhaus, Universität Frankfurt, Frauenklinik, Gotenstraße 6-8, D-65929, Frankfurt, Deutschland

    Volker Möbus

  3. Untere Kippstraße 21, D-69198, Schriesheim, Deutschland

    Dieter Alt

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adler-Ganal, S. (2002). Mammakarzinom in Schwangerschaft und Stillzeit. In: Kreienberg, R., Volm, T., Möbus, V., Alt, D. (eds) Management des MAMMAKARZINOMS. Onkologie Aktuell . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08460-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08460-1_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-08461-8

  • Online ISBN: 978-3-662-08460-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation